Search Results 1261-1270 of 17060 for mesenteric fat and ibd

1. Medical Research & Education - Mayo Clinic News Network

   ... IBD. Research. First Efficacy Study of Investigational Antiviral Therapy for COVID-19 Infection in Patients with IBD. Lynda De Widt. November 7, 2022. Science ...

2. Exploring the use of MRE and liver stiffness measurement to guide treatment and predict outcomes in patients with NAFLD - Mayo Clinic

   ... obtained through magnetic resonance elastography (MRE) can help individualize care and predict outcomes in patients with nonalcoholic fatty liver disease.

3. Primary sclerosing cholangitis - Doctors and departments - Mayo Clinic

   Liver damage can result from this potentially serious disease in which scarring blocks the bile ducts. A liver transplant is the only known cure.

4. Medical Research & Education - Mayo Clinic News Network

   What is inflammatory bowel disease? Jennifer O'Hara. April 25, 2019. Majority of U.S. states restrict ...

5. Study to Determine the Effectiveness of “The Perfect Waist Circumference Measuring Device" - Mayo Clinic

   The purpose of this study is to determine whether abdominal subcutaneous and visceral fat measured by diagnostic imaging correlates with waist circumferences ...

6. Gastroenterology and Hepatology - Clinical trials

   This research study is being done to create a collection of biospecimens (blood, urine, cyst fluid, bile, kidney or liver tissue, etc.) ...

7. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

   ... fatty liver disease..., Primary biliary cholangitis, Primary sclerosing cholangitis, Portal hypertension, Autoimmune hepatitis, Hemochromatosis, Alcoholic ...

8. Primary sclerosing cholangitis (PSC) - Doctors and departments - Mayo Clinic

   nalcoholic fatty liver disease, Primary biliary cholangitis ... Fatty liver disease. Show more areas of focus for Nicole M. Loo, M.D. ...

9. Sclerosing mesenteritis - Mayo Clinic

   Carol Bolton discusses her experience receiving treatment for sclerosing mesenteritis at Mayo Clinic.

10. A Study To Evaluate The Effectiveness And Safety Of Elafibranor For Patients With Nonalcoholic Fatty Liver Disease - Mayo Clinic

    Clinical Trials · A Study To Evaluate The Effectiveness And Safety Of Elafibranor For Patients With Nonalcoholic Fatty Liver Disease · More about research at Mayo ...